Literature DB >> 8036007

v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells.

J L Cleveland1, J Troppmair, G Packham, D S Askew, P Lloyd, M González-Garcia, G Nuñez, J N Ihle, U R Rapp.   

Abstract

Interleukin-3 (IL-3) is required for the proliferation, survival and differentiation of myeloid progenitors. In the absence of IL-3, murine myeloid 32D.3 cells accumulate in the G1 phase of the cell cycle and subsequently undergo programmed cell death, or apoptosis. Here we demonstrate that enforced expression of the v-raf oncogene suppresses apoptosis of myeloid 32D.3 cells following the withdrawal of IL-3. Surprisingly, steady state levels of Bcl-2, an oncogene known to suppress apoptosis, were not dependent upon IL-3 in 32D.3 cells and its levels were not augmented in v-raf clones. This suggests that ability of v-raf to suppress apoptosis in the absence of ligand is either Bcl-2 independent or that v-raf kinase promotes Bcl-2 function. v-raf also promoted growth of these cells in the presence of IL-3. v-raf clones proliferated at an increased rate due to a shortened G1 phase and had decreased requirements for IL-3 for growth. Therefore, transformation of myeloid cells by v-raf involves signaling pathways which promote both cell cycle progression and cell survival.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036007

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.

Authors:  P Erhardt; E J Schremser; G M Cooper
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Cortical migration defects in mice expressing A-RAF from the B-RAF locus.

Authors:  Guadalupe Camarero; Oleg Yu Tyrsin; Chaomei Xiang; Verena Pfeiffer; Sandra Pleiser; Stefan Wiese; Rudolf Götz; Ulf R Rapp
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

3.  Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways.

Authors:  F W Quelle; J Wang; J Feng; D Wang; J L Cleveland; J N Ihle; G P Zambetti
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

4.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.

Authors:  D Woods; D Parry; H Cherwinski; E Bosch; E Lees; M McMahon
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.

Authors:  G Packham; E L White; C M Eischen; H Yang; E Parganas; J N Ihle; D A Grillot; G P Zambetti; G Nuñez; J L Cleveland
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

6.  Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors.

Authors:  M Florio; M C Hernandez; H Yang; H K Shu; J L Cleveland; M A Israel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 7.  Signal transduction by Ras-like GTPases: a potential target for anticancer drugs.

Authors:  M Spaargaren; J R Bischoff; F McCormick
Journal:  Gene Expr       Date:  1995

8.  Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.

Authors:  Mandayam O Nandan; Hong S Yoon; Weidong Zhao; Lillian A Ouko; Sengthong Chanchevalap; Vincent W Yang
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

9.  E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis.

Authors:  S W Hiebert; G Packham; D K Strom; R Haffner; M Oren; G Zambetti; J L Cleveland
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

10.  Survival signaling by C-RAF: mitochondrial reactive oxygen species and Ca2+ are critical targets.

Authors:  Andrey V Kuznetsov; Julija Smigelskaite; Christine Doblander; Manickam Janakiraman; Martin Hermann; Martin Wurm; Stefan F Scheidl; Robert Sucher; Andrea Deutschmann; Jakob Troppmair
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.